Jeil Pharmaceutical acquires European EDQM approval for ‘cephalosporin’ ingredient

Published: 2017-07-13 16:26:00
Updated: 2017-07-13 14:30:43

Jeil Pharmaceutical(CEO/President Suk-Jae Sung) announced ‘cefpodoxime’ manufactured at the Baekam Factory’s ‘cephalosporin’ manufacturing facility located in Cheoin-gu, Yongin-si, Gyeonggi-do acquired approval from the European Directorate for the Quality of Medicines(EDQM).

The company had car...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.